Slide 1Asthma Physiology and Natural Support Options Catherine Oshin Nat 307 Module 11 Discuss the physiology of asthma. What natural support options are available? Slide…

Slide 1 Slide 2 csupharmacol.com Pharmacology Slide 3 Chapter 1.Introduction About Pharmacology Chapter 2.Pharmacokinetics What the body does to a drug Chapter 3.Pharmacodynamics…

Slide 1Monika Kawohl Principal Statistical Programmer Accovion GmbH, Marburg, Germany New FDA Documents - Discussion of Implementation Considerations Slide 2 German Speaking…

Slide 1ADaM IG, May 2008 ADaM Implementation Guide: Its Almost Here. Are You Ready? Sandra Minjoe Principal Statistical Programmer Analyst Genentech, Inc Slide 2 ADaM IG,…

Slide 11 Off-Label Use of Medications in Workers Compensation Matthew Foster, PharmD, BCPS PMSI Clinical Services Slide 2 2 Objectives Overview of off-label prescribing Overview…

Slide 1Prosecutorial Perspective on Off- Label Promotion Virginia Gibson Assistant U.S. Attorney National Pharma AudioConference, October 26, 2004 Slide 2 The views expressed…

Slide 1 Slide 2 The Constitutional Convention May-September 1787 Goal: Amend the Articles of Confederation Ideas behind the Constitution: –The Enlightenment –3-part government…

Slide 1Labeling claims for patient- reported outcomes (A regulatory perspective) FDA/Industry Workshop Washington, DC September 16, 2005 Lisa A. Kammerman, Ph.D. Division…

Slide 1Surrogate Markers and its role in the Drug Development Process Aloka G. Chakravarty, Ph.D. Director, Biologics Therapeutics Statistical Staff [email protected]…

Slide 11 Revising FDAs Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests FDA/Industry Statistics Workshop September 28-29, 2006 Kristen Meier,…